I agree that this site is using cookies. You can find further informations here.
X
Leppa, Sirpa
220  results:
Search for persons X
?
1

MRD-driven treatment with venetoclax-R2 in mantle cell lymp..:

Jerkeman, Mats ; Kolstad, Arne ; Hutchings, Martin...
Blood Advances.  8 (2024)  2 - p. 407-415 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Inflammatory and subtype-dependent serum protein signatures..:

Arffman, Maare ; Meriranta, Leo ; Autio, Matias...
Med.  5 (2024)  6 - p. 583-602.e5 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Elderly long-term survivors in the Nordic phase II study wi..:

Pulczynski, Elisa Jacobsen ; Simonsen, Mikkel Runason ; Kuittinen, Outi...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Serum protein profiling reveals an inflammation signature a..:

Karihtala, Peeter ; Leivonen, Suvi-Katri ; Puistola, Ulla...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S33-S34 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Ibrutinib combined with immunochemotherapy with or without ..:

Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva...
The Lancet.  403 (2024)  10441 - p. 2293-2306 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology.  11 (2024)  8 - p. e593-e605 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signal..:

Meriranta, Leo ; Sorri, Selma ; Huse, Kanutte...
Blood Cancer Discovery.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Gut microbiome-derived bacterial extracellular vesicles in ..:

Mishra, Surbhi ; Tejesvi, Mysore Vishakantegowda ; Hekkala, Jenni...
Journal of Advanced Research.  , 2024
Link: https://doi.org/10.1016/..
 
?
10

IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S454 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Transformation and survival in marginal zone lymphoma: a Fi..:

Kalashnikov, Ilja ; Tanskanen, Tomas ; Viisanen, Leevi...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL..:

Jerkeman, Mats ; Leppä, Sirpa ; Hamfjord, Julian...
HemaSphere.  7 (2023)  S3 - p. e91359ec , 2023
Link: https://doi.org/10.1097/..
 
?
13

Characterization and clinical impact of the tumor microenvi..:

Leivonen, Suvi-Katri ; Friman, Terhi ; Autio, Matias...
Haematologica.  108 (2023)  11 - p. 3044-3057 , 2023
Link: https://doi.org/10.3324/..
 
?
14

S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVID..:

Sureda, Anna ; Falchi, Lorenzo ; Leppa, Sirpa...
HemaSphere.  7 (2023)  S3 - p. e5547136 , 2023
Link: https://doi.org/10.1097/..
 
?
15

P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REF..:

Hutchings, Martin ; Carlo-Stella, Carmelo ; Morschhauser, Franck...
HemaSphere.  7 (2023)  S3 - p. e458981a , 2023
Link: https://doi.org/10.1097/..
 
1-15